Cargando…

The Profile and Clinical Significance of ITGB2 Expression in Non-Small-Cell Lung Cancer

Integrins are involved in extracellular and intracellular signaling and are often aberrantly expressed in tumors. Integrin beta 2 (ITGB2) has previously been demonstrated to be correlated with the host defense. However, the expression profile and role of ITGB2 in non-small-cell lung cancer (NSCLC) r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zu, Lingling, He, Jinling, Zhou, Ning, Zeng, Jingtong, Zhu, Yifang, Tang, Quanying, Jin, Xin, Zhang, Lei, Xu, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655748/ https://www.ncbi.nlm.nih.gov/pubmed/36362654 http://dx.doi.org/10.3390/jcm11216421

Ejemplares similares

A Review of Biomarkers and Their Clinical Impact in Resected Early-Stage Non-Small-Cell Lung Cancer
por: Cao, Weibo, et al.
Publicado: (2023)

Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation
por: Zhang, Bo, et al.
Publicado: (2022)

Clinical significance of preoperative neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio in the prognosis of resected early‐stage patients with non‐small cell lung cancer: A meta‐analysis
por: Cao, Weibo, et al.
Publicado: (2022)

Lobe‐specific analysis of perioperative chemotherapy for non‐small cell lung cancer patients
por: Lei, Xi, et al.
Publicado: (2023)

Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer
por: Wu, Pancheng, et al.
Publicado: (2019)

Use of savolitinib as neoadjuvant therapy for non–small cell lung cancer patient with MET exon 14 skipping alterations: A case report
por: Zhang, Yu, et al.
Publicado: (2022)

Identification of a novel oxidative stress-related prognostic model in lung adenocarcinoma
por: Zhu, Yifan, et al.
Publicado: (2022)

PD-1/PD-L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)
por: Tang, Quanying, et al.
Publicado: (2023)

Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma
por: Liang, Qiuli, et al.
Publicado: (2021)

Comprehensive analyses of one-carbon metabolism related genes and their association with prognosis, tumor microenvironment, chemotherapy resistance and immunotherapy in lung adenocarcinoma
por: Zhou, Ning, et al.
Publicado: (2022)

Integrin and gene network analysis reveals that ITGA5 and ITGB1 are prognostic in non-small-cell lung cancer
por: Zheng, Weiqi, et al.
Publicado: (2016)

miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer
por: Ni, Ran, et al.
Publicado: (2015)

The expression and significance of long non-coding RNA ITGB2-AS1 in renal clear cell carcinoma
por: Zhou, Wei, et al.
Publicado: (2023)

Lobectomy versus sublobar resection for stage I (T1‐T2aN0M0) small cell lung cancer: A SEER population‐based propensity score matching analysis
por: Zhou, Ning, et al.
Publicado: (2022)

LncRNA ITGB2-AS1 Could Promote the Migration and Invasion of Breast Cancer Cells through Up-Regulating ITGB2
por: Liu, Mengyao, et al.
Publicado: (2018)

Establishment and characterization of a novel highly malignant lung cancer cell line ZX2021H derived from a metastatic lymph node lesion
por: Zu, Lingling, et al.
Publicado: (2022)

MicroRNA‐374b mediates the initiation of non‐small cell lung cancer by regulating ITGB1 and p53 expressions
por: Zhao, Meng, et al.
Publicado: (2020)

KCNF1 promotes lung cancer by modulating ITGB4 expression
por: Chen, Ching-Yi, et al.
Publicado: (2022)

ITGB1-DT Facilitates Lung Adenocarcinoma Progression via Forming a Positive Feedback Loop With ITGB1/Wnt/β-Catenin/MYC
por: Chang, Ruimin, et al.
Publicado: (2021)

High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1
por: Liang, Zhu, et al.
Publicado: (2017)

Integrative Analyses Identify Osteopontin, LAMB3 and ITGB1 as Critical Pro-Metastatic Genes for Lung Cancer
por: Wang, Xiao-Min, et al.
Publicado: (2013)

LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
por: Jin, Xin, et al.
Publicado: (2021)

Knockdown of long non‐coding RNA linc‐ITGB1 inhibits cancer stemness and epithelial‐mesenchymal transition by reducing the expression of Snail in non‐small cell lung cancer
por: Guo, Lili, et al.
Publicado: (2018)

Extracellular Vesicle ITGAM and ITGB2 Mediate Severe Acute Pancreatitis-Related Acute Lung Injury
por: Hu, Qian, et al.
Publicado: (2023)

Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG)
por: Liu, He, et al.
Publicado: (2023)

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors
por: Guo, Linlin, et al.
Publicado: (2023)

EccDNA-oriented ITGB7 expression in breast cancer
por: Yang, Lin, et al.
Publicado: (2022)

Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer
por: Hong, Soon-Ki, et al.
Publicado: (2018)

Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition
por: Li, Yuexian, et al.
Publicado: (2021)

LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis
por: Chen, Huiyong, et al.
Publicado: (2023)

Activation of GRP78 ATPase suppresses A549 lung cancer cell migration by promoting ITGB4 degradation
por: Ning, Junya, et al.
Publicado: (2022)

Clinical significance of Girdin expression detected by immunohistochemistry in non-small cell lung cancer
por: SONG, JING-YING, et al.
Publicado: (2014)

The expression profile and clinic significance of the SIX family in non-small cell lung cancer
por: Liu, Qian, et al.
Publicado: (2016)

MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance
por: Lan, Dong, et al.
Publicado: (2015)

ITGB3 promotes cisplatin resistance in osteosarcoma tumors
por: Li, Qian, et al.
Publicado: (2023)

Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement
por: Zhou, Ning, et al.
Publicado: (2022)

Identifying ITGB2 as a Potential Prognostic Biomarker in Ovarian Cancer
por: Li, Chanyuan, et al.
Publicado: (2023)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells
por: Fuentes, Pedro, et al.
Publicado: (2020)

Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer
por: Tang, Tianjiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3m32j1g3c7ve2ovolg1ts9c2gc